newest glp-1 drug Drugs: 6 Things We've Learned About Their Effects Weight loss drugs don't work
Description
Gke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, et al
If pancreatitis is suspected, the patient should discontinue exenatide immediately and seek medical attention
In a small group with T2D, SAR425899 improved fasting glucose and glucose tolerance after a mixed meal ( Several other multi-agonists capable of co-agonism of the GLP-1 and glucagon receptors are currently in development including BI 456906 (Boehringer Ingelheim), LY3305677 (Lilly) LY4347943 (Lilly), JNJ-54729518 (J&J), HM15211 (Hanmi), NNC9204-1706 (Novo), Alt-801 (Altimmune) and G3215 (Imperial College/Zihipp Ltd.) see Table 1
Spichak, S
